New antibiotic approach may cut infections after pancreatic surgery
NCT ID NCT07531420
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 117 patients who had pancreatic surgery to see if changing the antibiotic given before surgery could reduce infections. The researchers compared an older antibiotic (cephalosporin) with a newer one (piperacillin/tazobactam) based on local bacteria patterns. The goal was to find the best way to prevent surgical site infections while avoiding overuse of strong antibiotics.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
piperacillin/tazobactam (an antibiotic)
What this could lead to
If successful, this could help hospitals choose the best antibiotic to prevent infections after pancreatic surgery, reducing complications and the need for stronger antibiotics.
What could go wrong
This is a small, single-center study, so results may not apply to other hospitals. The infection risk depends on local bacteria, so the best antibiotic may vary by location.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Nancy
Nancy, France